TrialBritish journal of clinical pharmacology2015

A pharmacokinetic comparison of anrukinzumab, an anti- IL-13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients.

Fei Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.